Back
Nektar Therapeutics Vs. Theriva Biologics Industry Stock Comparison
Sell
41
NKTR
Nektar Therapeutics
Last Price:
1.30
Seasonality Move:
4.53%
Buy
74
TOVX
Theriva Biologics
Last Price:
3.89
Seasonality Move:
-14.26%
Sell
41
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
- The current Nektar Therapeutics [NKTR] share price is $1.29. The Score for NKTR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Theriva Biologics (TOVX)
is a Buy
Is Theriva Biologics a Buy, Sell or Hold?
- The current Theriva Biologics [TOVX] share price is $3.80. The Score for TOVX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- TOVX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $1.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $3.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TOVX is experiencing slight selling pressure.
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 53.51 | Buy |
Chaikin Money Flow: | 664758 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.2 - 1.32) | Buy |
Bollinger Bands (100): | (1.16 - 1.54) | Sell |
TOVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.69 | Buy |
Relative Strength Index (14 RSI): | 45.75 | Sell |
Chaikin Money Flow: | -12459 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.32 - 4.72) | Buy |
Bollinger Bands (100): | (-0.5 - 2.42) | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.28 | Buy |
20-day SMA: | 1.26 | Buy |
50-day SMA: | 1.28 | Buy |
200-day SMA: | 1.07 | Buy |
8-day EMA: | 1.27 | Buy |
20-day EMA: | 1.26 | Buy |
50-day EMA: | 1.26 | Buy |
200-day EMA: | 1.19 | Buy |
TOVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.88 | Sell |
20-day SMA: | 3.73 | Buy |
50-day SMA: | 1.63 | Buy |
200-day SMA: | 0.72 | Buy |
8-day EMA: | 3.86 | Sell |
20-day EMA: | 3.36 | Buy |
50-day EMA: | 2.2 | Buy |
200-day EMA: | 1 | Buy |
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and a decrease next year of $0.06 per share.
Theriva Biologics Earnings Growth & TOVX Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
Nektar Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Theriva Biologics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |